Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
1.84
-0.53 (-22.36%)
At close: Jun 17, 2025, 3:59 PM
1.78
-3.24%
After-hours: Jun 17, 2025, 07:59 PM EDT

Immuneering Revenue

Immuneering reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Immuneering generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
54
Market Cap
66.18M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.